Literature DB >> 3541116

Immunoreactive glutamic acid decarboxylase in the trigeminal nucleus caudalis of the cat: a light- and electron-microscopic analysis.

A I Basbaum, E J Glazer, W Oertel.   

Abstract

This study used antisera directed against glutamic acid decarboxylase (GAD), the biosynthetic enzyme for gamma-aminobutyric acid (GABA), to examine the light- and electron-microscopic distribution of presumed GABA-ergic synapses in the medullary homologue of the cat spinal dorsal horn, the trigeminal nucleus caudalis. At the light-microscopic level, immunoreactive terminals were concentrated in the superficial dorsal horn, laminae I and II. Colchicine was generally ineffective in revealing the distribution of cell bodies. However, in two successful cases, the majority of labeled cells were found in the magnocellular layer, ventral to the substantia gelatinosa, a region that had a lower density of immunoreactive terminals. Other labeled neurons were scattered in laminae I and II. A variety of synaptic arrangements were found at the electron-microscopic level. These derived from two types of labeled terminals. One contained both small round vesicles and large dense-cored vesicles. The second contained small round and pleomorphic vesicles. Some immunoreactive GAD terminals contained a few flat vesicles. Labeled terminals predominantly formed axodendritic synapses, via symmetrical contacts. Several axoaxonic arrangements were also observed. In most cases, the GAD terminal (which did not contain dense-cored vesicles) was presynaptic to another vesicle-containing profile, including the scalloped central terminal thought to derive from primary afferents. Another population of labeled GAD terminals was found postsynaptic to unlabeled vesicle-containing profiles, including central terminals. These data indicate that inhibitory GABA-ergic controls in the trigeminal nucleus caudalis involve both presynaptic and postsynaptic mechanisms and are probably mediated via direct contacts onto ascending projection neurons, as well as via synaptic contacts onto nociceptive primary afferent fibers. The transmission of nociceptive messages by neurons of the spinal cord dorsal horn and trigeminal nucleus caudalis is subject to a variety of segmental and supraspinal controls. Pharmacological and electrophysiological studies have implicated the biogenic amines serotonin and norepinephrine, and the endogenous opioid peptides enkephalin and dynorphin, in those controls (Basbaum and Fields, 1978, 1984; Basbaum et al., 1983; Basbaum, 1985).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3541116     DOI: 10.3109/07367228609144599

Source DB:  PubMed          Journal:  Somatosens Res        ISSN: 0736-7244


  6 in total

1.  GABA receptors modulate trigeminovascular nociceptive neurotransmission in the trigeminocervical complex.

Authors:  R J Storer; S Akerman; P J Goadsby
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

2.  The trigeminally evoked blink reflex. II. Mechanisms of paired-stimulus suppression.

Authors:  J J Pellegrini; C Evinger
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

3.  Long-term, dynamic synaptic reorganization after GABAergic precursor cell transplantation into adult mouse spinal cord.

Authors:  Ida J Llewellyn-Smith; Allan I Basbaum; João M Bráz
Journal:  J Comp Neurol       Date:  2017-11-13       Impact factor: 3.215

4.  Attenuation by valproate of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin.

Authors:  F M Cutrer; V Limmroth; G Ayata; M A Moskowitz
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

5.  Coexistence of GABA- and choline acetyltransferase (ChAT)-like immunoreactivity in the hypoglossal nucleus of the rat.

Authors:  M S Davidoff; W Schulze
Journal:  Histochemistry       Date:  1988

6.  Changes in synaptic transmission of substantia gelatinosa neurons after spinal cord hemisection revealed by analysis using in vivo patch-clamp recording.

Authors:  Yuji Kozuka; Mikito Kawamata; Hidemasa Furue; Takashi Ishida; Satoshi Tanaka; Akiyoshi Namiki; Michiaki Yamakage
Journal:  Mol Pain       Date:  2016-08-28       Impact factor: 3.395

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.